{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:38:56Z","timestamp":1792132736675,"version":"4.4.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"Abstract<\/jats:title>\n \n STUDY QUESTION<\/jats:title>\n What is the association between insulin resistance (IR), metformin treatment, and the outcomes of IVF in IR infertile women without polycystic ovarian syndrome (non-PCOS)?<\/jats:p>\n <\/jats:sec>\n \n SUMMARY ANSWER<\/jats:title>\n IR among non-PCOS infertile women was associated with worse IVF outcomes compared to insulin-sensitive (IS) infertile women, and metformin treatment prior to embryo transfer (ET) was associated with improved reproductive outcomes.<\/jats:p>\n <\/jats:sec>\n \n WHAT IS KNOWN ALREADY<\/jats:title>\n Endometrium insulin-mediated glucose uptake is essential in human embryo implantation, decidualization, and pregnancy. IR has been described as a risk factor for spontaneous abortion in women undergoing IVF. While this condition has been studied in the context of PCOS and its association with poorer reproductive outcomes, with Metformin proposed as a possible treatment, there is a lack of studies examining the role of IR in non-PCOS infertile women.<\/jats:p>\n <\/jats:sec>\n \n STUDY DESIGN, SIZE, DURATION<\/jats:title>\n Observational, multicenter, retrospective cohort study with clinical data from private fertility centers in Spain collected between January 2015 to November 2023. From 1659 patients a total of 1033 women met all the inclusion criteria and had available data for analysis.<\/jats:p>\n <\/jats:sec>\n \n PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n The study included non-PCOS infertile women between 18 and 45\u2009years old, with a BMI \u226430\u2009kg\/m2, available oral glucose tolerance test (OGTT) results, and an indication for IVF and ET using donated oocytes. The study population was stratified based on OGTT results in IS women (n\u2009=\u2009718) and in IR women (n\u2009=\u2009315). Among IR patients, we identified 198 who were not exposed to metformin at their first ET and 117 who were Metformin-exposed prior to their first ET. IVF outcomes, including biochemical pregnancy, biochemical miscarriage, clinical pregnancy, clinical miscarriage, and live birth rates were evaluated as primary outcomes in IS and not exposed IR groups. The association between metformin exposure and IVF outcomes among IR patients was assessed as secondary outcomes.<\/jats:p>\n <\/jats:sec>\n \n MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n The prevalence of IR in non-PCOS infertile women was 30.5%. Compared to the IS group, unexposed IR women had a higher risk of clinical miscarriage [26.3% vs 17.6%; adjusted relative risk (aRR)=1.439 (1.078\u20131.921); P\u2009=\u20090.013] and lower live birth rates [9.6% vs 24.5%; aRR=0.422 (0.269\u20130.663); P\u2009&lt;\u20090.001]. Alternatively, IR patients exposed to Metformin had a higher risk of clinical pregnancy [53.9% vs 35.9%; aRR\u2009=\u20091.467 (1.137\u20131.892) P\u2009=\u20090.003], lower risk of clinical miscarriage [13.7% vs 26.3%; aRR\u2009=\u20090.481 (0.288\u20130.804), P\u2009=\u20090.005], and higher live birth rates [40.2% vs 9.6%; aRR\u2009=\u20094.069 (2.445\u20136.774), P\u2009&lt;\u20090.001] than unexposed IR patients.<\/jats:p>\n <\/jats:sec>\n \n LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n Due to its retrospective nature, the inherent limitations of this pilot study are the potential heterogeneity and confounding factors among the study groups.<\/jats:p>\n <\/jats:sec>\n \n WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n The findings of this study provide valuable insights into the role of the endometrial environment on reproductive outcomes in the context of IR among non-PCOS infertile women. Nevertheless, future prospective studies with larger sample sizes are essential to corroborate these findings to broader populations.<\/jats:p>\n <\/jats:sec>\n \n STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n This project was supported by the Spanish Ministry of Universities through the Formacion de Profesorado Universitario Program (FPU21\/01178) awarded to A.B.A, the Instituto de Salud Carlos III, cofounded by the European Social Fund (ESF) \u2018Investing in your future\u2019 through the Miguel Servet Program (CP20\/00120) awarded to H.F. and (CP19\/00149) awarded to I.C. and Sara Borrell Contract (CD23\/00157) awarded to A.C. The authors have no conflicts of interest to disclose.<\/jats:p>\n <\/jats:sec>\n \n TRIAL REGISTRATION NUMBER<\/jats:title>\n N\/A.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/humrep\/deaf100","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T19:57:41Z","timestamp":1748548661000},"page":"1562-1569","source":"Crossref","is-referenced-by-count":8,"title":["Association of insulin resistance with in vitro<\/i> fertilization outcomes in women without polycystic ovarian syndrome: potential improvement with metformin treatment"],"prefix":"10.1093","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3474-6328","authenticated-orcid":false,"given":"Ana Bel\u00e9n","family":"Albert","sequence":"first","affiliation":[{"name":"IVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigaci\u00f3n Sanitaria La Fe (IIS La Fe), Department of Reproductive Medicine , Valencia,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0520-4673","authenticated-orcid":false,"given":"Ana","family":"Corach\u00e1n","sequence":"additional","affiliation":[{"name":"IVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigaci\u00f3n Sanitaria La Fe (IIS La Fe), Department of Reproductive Medicine , Valencia,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ju\u00e1rez-Barber","sequence":"additional","affiliation":[{"name":"IVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigaci\u00f3n Sanitaria La Fe (IIS La Fe), Department of Reproductive Medicine , Valencia,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5929-2357","authenticated-orcid":false,"given":"Mauro","family":"Cozzolino","sequence":"additional","affiliation":[{"name":"IVIRMA Global Research Alliance, IVIRMA-Rome , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8254-863X","authenticated-orcid":false,"given":"Antonio","family":"Pellicer","sequence":"additional","affiliation":[{"name":"IVIRMA Global Research Alliance, IVIRMA-Rome , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Alecsandru","sequence":"additional","affiliation":[{"name":"IVIRMA Global Research Alliance, IVIRMA-Madrid , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cervell\u00f3","sequence":"additional","affiliation":[{"name":"IVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigaci\u00f3n Sanitaria La Fe (IIS La Fe), Department of Reproductive Medicine , Valencia,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4302-7871","authenticated-orcid":false,"given":"Hortensia","family":"Ferrero","sequence":"additional","affiliation":[{"name":"IVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigaci\u00f3n Sanitaria La Fe (IIS La Fe), Department of Reproductive Medicine , Valencia,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"2025080101520587500_deaf100-B1","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.2337\/dc07-S042","article-title":"Diagnosis and classification of diabetes mellitus","volume":"30","author":"American Diabetes Association","year":"2007","journal-title":"Diabetes Care"},{"key":"2025080101520587500_deaf100-B2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4239\/wjd.v13.i3.129","article-title":"Markers of insulin resistance in polycystic ovary syndrome women: an update","volume":"13","author":"Amisi","year":"2022","journal-title":"World J Diabetes"},{"key":"2025080101520587500_deaf100-B3","doi-asserted-by":"crossref","first-page":"1100547","DOI":"10.3389\/fmed.2023.1100547","article-title":"The cut-off value for HOMA-IR discriminating the insulin resistance based on the SHBG level in women with polycystic ovary syndrome","volume":"10","author":"Biernacka-Bartnik","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"2025080101520587500_deaf100-B4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1186\/s12884-022-05256-z","article-title":"Insulin resistance in women with recurrent miscarriage: a systematic review and meta-analysis","volume":"22","author":"Cai","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025080101520587500_deaf100-B5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/biolre\/ioz102","article-title":"Glycogen in the uterus and fallopian tubes is an important source of glucose during early pregnancy","volume":"101","author":"Dean","year":"2019","journal-title":"Biol Reprod"},{"key":"2025080101520587500_deaf100-B6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Fauser","year":"2004","journal-title":"Fertil Steril"},{"key":"2025080101520587500_deaf100-B7","first-page":"827","article-title":"S\u00edndrome de resistencia a la insulina. estudio y manejo","volume":"24","author":"Fernando Carrasco","year":"2013","journal-title":"Rev M\u00e9d Cl\u00edn Las Condes"},{"key":"2025080101520587500_deaf100-B8","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1210\/jc.2017-01759","article-title":"Insulin regulates glycogen synthesis in human endometrial glands through increased GYS2","volume":"103","author":"Flannery","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2025080101520587500_deaf100-B9","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/ijms23031264","article-title":"Metformin and insulin resistance: a review of the underlying mechanisms behind changes in GLUT4-mediated glucose transport","volume":"23","author":"Herman","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025080101520587500_deaf100-B10","first-page":"1126","article-title":"Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome","volume":"86","author":"Jakubowicz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2025080101520587500_deaf100-B11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.14310\/horm.2002.1266","article-title":"Low-dose metformin improves pregnancy rate in in vitro fertilization repeaters without polycystic ovary syndrome: prediction of effectiveness by multiple parameters related to insulin resistance","volume":"9","author":"Jinno","year":"2010","journal-title":"Hormones"},{"key":"2025080101520587500_deaf100-B12","first-page":"e27433","article-title":"The effect of insulin resistance on ovulation induction with clomiphene citrate in non-polycystic ovary syndrome (PCOS) women","volume":"14","author":"Karnatak","year":"2022","journal-title":"Cureus"},{"key":"2025080101520587500_deaf100-B13","first-page":"109","article-title":"Insulin resistance: lifestyle and nutritional interventions","volume":"5","author":"Kelly","year":"2000","journal-title":"Altern Med Rev"},{"key":"2025080101520587500_deaf100-B14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and molecular mechanisms of metformin action","volume":"42","author":"Lamoia","year":"2021","journal-title":"Endocr Rev"},{"key":"2025080101520587500_deaf100-B15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.metabol.2010.07.024","article-title":"Misclassification of subjects with insulin resistance and associated cardiovascular risk factors by homeostasis model assessment index. Utility of a postprandial method based on oral glucose tolerance test","volume":"60","author":"Martinez-Hervas","year":"2011","journal-title":"Metabolism"},{"key":"2025080101520587500_deaf100-B16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0002-8703(96)90046-0","article-title":"MB fraction of cumulative creatine kinase correlates with insulin secretion in patients with acute myocardial infarction: insulin as a possible determinant of myocardial MB creatine kinase","volume":"131","author":"Matsui","year":"1996","journal-title":"Am Heart J"},{"key":"2025080101520587500_deaf100-B17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10815-022-02429-9","article-title":"The use of metformin in women with polycystic ovary syndrome: an updated review","volume":"39","author":"Notaro","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"2025080101520587500_deaf100-B18","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3390\/ijms21061973","article-title":"Physiologic events of embryo implantation and decidualization in human and non-human primates","volume":"21","author":"Ochoa-Bernal","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025080101520587500_deaf100-B19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1530\/ror.0.0030077","article-title":"Glucose transporters in preimplantation development","volume":"3","author":"Pantaleon","year":"1998","journal-title":"Rev Reprod"},{"key":"2025080101520587500_deaf100-B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2013.tb00484.x","article-title":"Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training","volume":"3","author":"Roberts","year":"2013","journal-title":"Compr Physiol"},{"key":"2025080101520587500_deaf100-B21","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1177\/1933719111430993","article-title":"Endometrial abnormality in women with polycystic ovary syndrome","volume":"19","author":"Shang","year":"2012","journal-title":"Reprod Sci"},{"key":"2025080101520587500_deaf100-B22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1358\/dot.2008.44.4.1138124","article-title":"Metformin: a review","volume":"44","author":"Strack","year":"2008","journal-title":"Drugs Today"},{"key":"2025080101520587500_deaf100-B23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/diacare.23.3.295","article-title":"Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity","volume":"23","author":"Stumvoll","year":"2000","journal-title":"Diabetes Care"},{"key":"2025080101520587500_deaf100-B24","doi-asserted-by":"crossref","first-page":"592495","DOI":"10.3389\/fendo.2020.592495","article-title":"High BMI and insulin resistance are risk factors for spontaneous abortion in patients with polycystic ovary syndrome undergoing assisted reproductive treatment: a systematic review and meta-analysis","volume":"11","author":"Sun","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025080101520587500_deaf100-B25","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5582\/ddt.2015.01207","article-title":"Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: developments in research and prospects for the future","volume":"9","author":"Tang","year":"2015","journal-title":"Drug Discov Ther"},{"key":"2025080101520587500_deaf100-B26","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/humrep\/del025","article-title":"The use of metformin for women with PCOS undergoing IVF treatment","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"2025080101520587500_deaf100-B27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","journal-title":"Physiol Rev"},{"key":"2025080101520587500_deaf100-B28","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1210\/jc.2006-1123","article-title":"Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment","volume":"92","author":"Tian","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2025080101520587500_deaf100-B29","doi-asserted-by":"crossref","first-page":"1176623","DOI":"10.3389\/fendo.2023.1176623","article-title":"Lights and shadows on the use of metformin in pregnancy: from the preconception phase to breastfeeding and beyond","volume":"14","author":"Tosti","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025080101520587500_deaf100-B30","first-page":"CD006105","article-title":"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome","volume":"12","author":"Tso","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2025080101520587500_deaf100-B31","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3390\/jcm8101559","article-title":"The association between adult weight gain and insulin resistance at middle age: mediation by visceral fat and liver fat","volume":"8","author":"Verkouter","year":"2019","journal-title":"J Clin Med"},{"key":"2025080101520587500_deaf100-B32","doi-asserted-by":"crossref","first-page":"703671","DOI":"10.3389\/fcell.2021.703671","article-title":"Endometrial glucose transporters in health and disease","volume":"9","author":"Vrhovac Maduni\u0107","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2025080101520587500_deaf100-B33","doi-asserted-by":"crossref","first-page":"734638","DOI":"10.3389\/fendo.2021.734638","article-title":"Insulin resistance adversely affect IVF outcomes in lean women without PCOS","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025080101520587500_deaf100-B34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s40814-023-01388-x","article-title":"Effect of lifestyle or metformin interventions before IVF\/ICSI treatment on infertile women with overweight\/obese and insulin resistance: a factorial design randomised controlled pilot trial","volume":"9","author":"Wang","year":"2023","journal-title":"Pilot Feasibility Stud"},{"key":"2025080101520587500_deaf100-B35","doi-asserted-by":"crossref","first-page":"880518","DOI":"10.3389\/fendo.2022.880518","article-title":"Homeostatic model assessment for insulin resistance is associated with late miscarriage in non-dyslipidemic women undergoing fresh IVF\/ICSI embryo transfer","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025080101520587500_deaf100-B36","doi-asserted-by":"crossref","first-page":"e4526","DOI":"10.1097\/MD.0000000000004526","article-title":"Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis","volume":"95","author":"Zeng","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2025080101520587500_deaf100-B37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/cen.14050","article-title":"Effect of hyperinsulinaemia and insulin resistance on endocrine, metabolic and fertility outcomes in women with polycystic ovary syndrome undergoing ovulation induction","volume":"91","author":"Zhang","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025080101520587500_deaf100-B38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","article-title":"Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment","volume":"16","author":"Zhao","year":"2023","journal-title":"J Ovarian Res"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/40\/8\/1562\/63400869\/deaf100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/40\/8\/1562\/63400869\/deaf100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T05:52:28Z","timestamp":1754027548000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/40\/8\/1562\/8153001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,5,29]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaf100","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,5,29]]}}}